| Product Code: ETC7566695 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In the Indonesia hemostatic agents market, the import trend experienced a decline, with a growth rate of -8.17% from 2023 to 2024. The compound annual growth rate (CAGR) for imports over the period 2020-2024 stood at -4.9%. This negative import momentum can be attributed to shifts in demand dynamics or changes in trade policies impacting market stability.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Hemostatic Agents Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Hemostatic Agents Market Revenues & Volume, 2021 & 2031F |
3.3 Indonesia Hemostatic Agents Market - Industry Life Cycle |
3.4 Indonesia Hemostatic Agents Market - Porter's Five Forces |
3.5 Indonesia Hemostatic Agents Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Indonesia Hemostatic Agents Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Indonesia Hemostatic Agents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing number of surgical procedures in Indonesia |
4.2.2 Growing awareness about the benefits of hemostatic agents in controlling bleeding |
4.2.3 Technological advancements in hemostatic agent products |
4.3 Market Restraints |
4.3.1 High cost associated with hemostatic agents |
4.3.2 Limited availability of advanced hemostatic agents in certain regions of Indonesia |
4.3.3 Stringent regulatory requirements for approval of hemostatic agent products |
5 Indonesia Hemostatic Agents Market Trends |
6 Indonesia Hemostatic Agents Market, By Types |
6.1 Indonesia Hemostatic Agents Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Hemostatic Agents Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Indonesia Hemostatic Agents Market Revenues & Volume, By Active Agents, 2021- 2031F |
6.1.4 Indonesia Hemostatic Agents Market Revenues & Volume, By Passive Agents, 2021- 2031F |
6.1.5 Indonesia Hemostatic Agents Market Revenues & Volume, By Combination, 2021- 2031F |
6.2 Indonesia Hemostatic Agents Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Hemostatic Agents Market Revenues & Volume, By Large Hospital (500+ Beds), 2021- 2031F |
6.2.3 Indonesia Hemostatic Agents Market Revenues & Volume, By Medium Hospital (250-499 Beds), 2021- 2031F |
6.2.4 Indonesia Hemostatic Agents Market Revenues & Volume, By Small Hospitals (Less than 250 Beds), 2021- 2031F |
7 Indonesia Hemostatic Agents Market Import-Export Trade Statistics |
7.1 Indonesia Hemostatic Agents Market Export to Major Countries |
7.2 Indonesia Hemostatic Agents Market Imports from Major Countries |
8 Indonesia Hemostatic Agents Market Key Performance Indicators |
8.1 Number of surgical procedures performed annually in Indonesia |
8.2 Adoption rate of hemostatic agents in different medical specialties |
8.3 Investment in research and development for new hemostatic agent products |
9 Indonesia Hemostatic Agents Market - Opportunity Assessment |
9.1 Indonesia Hemostatic Agents Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Indonesia Hemostatic Agents Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Indonesia Hemostatic Agents Market - Competitive Landscape |
10.1 Indonesia Hemostatic Agents Market Revenue Share, By Companies, 2024 |
10.2 Indonesia Hemostatic Agents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |